La Jolla Labs

04/29/2026

National DNA Day commemorates the successful completion of the Human Genome Project in 2003 and the discovery of DNA's double helix in 1953. La Jolla Labs' celebrates this day to honor past achievements in nucleic acid science and as a company we hope to build upon this knowledge through RNA therapeutics research.

04/28/2026

April 28th is KIF1A Day. KIF1A is a gene that is essential for the healthy function of the nervous system.

A mutation in this gene can cause KAND (KIF1A Associated Neurological Disorder), an ultrarare progressive neurodegenerative disorder.

Read more about the function of KIF1A and this ultrarare condition in our blog here:

KIF1A-related disorders are a group of genetic disorders caused by one or more mutations in the KIF1A gene [1]. These mutations cause changes in the microtubule (MT) motor protein, disrupting the motor domain’s ability to transport specific synaptic vesicle precursors in axons, leading to KIF1A-As...

04/23/2026

Today is World Laboratory Day! Perla J. Sandoval and Geramie Shaver celebrate today by wearing their PPE and exercising those thumbs with their pipettes.

04/15/2026

Today is April 15th, International Pompe Day, created to foster international awareness of Pompe Disease. Pompe disease is a rare lysosomal storage disorder caused by a dysfunctional acid alpha-glucosidase enzyme, responsible for the lysosomal degradation of glycogen. This leads to glycogen accumulation in the body which causes cellular damage and dysfunction, tissue damage and organ dysfunction.

04/07/2026

La Jolla Labs celebrates World Health Day, observed on April 7th every year. This year the theme is “Together for health. Stand with science.” La Jolla Labs shares this philosophy by leveraging modern biology and computing technology and working together with patient families and partners to enable targeted therapeutic development for underrepresented rare disease communities.

04/04/2026

April is Fabry Disease Awareness Month! Fabry Disease is a rare genetic lysosomal storage disorder estimated to affect 1 in 100,000 people. People with this condition do not produce enough healthy versions of an enzyme called alpha-galactosidase A that breaks down fats. Consequently, these fats collect in the body's blood vessels and tissues, raising the risk of heart attack, stroke, and kidney failure.

03/16/2026

03/12/2026

We had a great time at the AI & Rare Disease event hosted by Our CEO Tamar Grossman was part of a panel discussing how AI is used in the rare disease field.

03/10/2026

This past weekend we celebrated International Women's Day, a global day celebrating the social, economic, cultural and political achievements of women. The day also marks a call to action for accelerating gender equality. La Jolla Labs strives for a diverse, inclusive, and equitable workplace and celebrates the women who are a part of our team.

01/23/2026

We’re proud to share that La Jolla Labs was recently featured in International Business Times as we approach our five-year milestone advancing RNA-based therapies for patients.

What started as a mission to remove barriers in therapeutic development has grown into a platform focused on computational RNA design, high-throughput screening, and close collaboration with clinicians and patient communities. Our work is driven by a simple goal: accelerate the path from scientific insight to real-world patient impact—especially for rare and under served diseases.

As we look ahead, we remain committed to expanding the possibilities of RNA therapeutics and applying our platform to increasingly complex indications. We’re grateful to our team, partners, and collaborators who make this progress possible.

Thank you for being part of the journey. The next chapter is just beginning.